पृष्ठ 1 से 16 परिणाम
BACKGROUND OF THE INVENTION
The present invention relates to compounds, pharmaceutical compositions, and methods for treating several conditions with prodrugs for phenylacetate as therapeutic agents.
FIELD OF THE INVENTION
Phenylalkanoic acids are known therapeutic agents for a variety of disorders.
BACKGROUND OF THE INVENTION
The present invention relates to compounds, pharmaceutical compositions, and methods for treating several conditions with prodrugs for phenylacetate as therapeutic agents.
1. Field of the Invention
Phenylalkanoic acids are known therapeutic agents for a variety of
BACKGROUND OF THE INVENTION
The present invention relates to compounds, pharmaceutical compositions, and methods for treating several conditions with prodrugs for phenylacetate as therapeutic agents.
FIELD OF THE INVENTION
Phenylalkanoic acids are known therapeutic agents for a variety of disorders.
CROSS-REFERENCE TO RELATED APPLICATION
This application is a national phase application and claims the benefit, under 35 U.S.C. .sctn.371, of PCT/CN2012/086045, filed on Dec. 6, 2012, which in turn claims priority to PCT international application No. PCT/CN2012/082278, filed on 28 Sep. 2012, the
BACKGROUND OF THE INVENTION
This invention relates to a compound having pharmacological activity, to compositions containing the compound, and to methods for the production and use of the compound. More particularly, the present invention concerns
BACKGROUND OF THE INVENTION
(a) Field of the Invention
The invention relates to a photodynamic treatment for the selective destruction of malignant leukemic cells without affecting the normal cells and without causing systemic toxicity for the patient.
(b) Description of Prior Art
Cancers are
BACKGROUND OF THE INVENTION
(a) Field of the Invention
The invention relates to a photodynamic treatment for the selective destruction of malignant leukemic cells without affecting the normal cells and without causing systemic toxicity for the patient.
(b) Description of Prior Art
Cancers are
FIELD OF THE INVENTION
This invention relates to novel 4-oxo-butenoic acid derivatives and to the use of these compounds and related compounds with novel biological activity in humans as therapeutic means for the prevention and treatment of the human breast cancer and claims the benefit of priority
FIELD OF THE INVENTION
This invention relates to novel 4oxo-butenoic acid derivatives and to the use of these compounds and related compounds with novel biological activity in humans as therapeutic means for the prevention and treatment of the human breast cancer and claims the benefit of priority
FIELD OF THE INVENTION
This invention relates to novel 4-oxo-butenoic acid derivatives and to the use of these compounds and related compounds with novel biological activity in humans as therapeutic means for the prevention and treatment of the human breast cancer and claims the benefit of priority
FIELD OF THE INVENTION
This invention relates to novel 4-oxo-butenoic acid derivatives and to the use of these compounds and related compounds with novel biological activity in humans as therapeutic means for the prevention and treatment of the human breast cancer and claims the benefit of priority
TECHNICAL FIELD
The present invention relates to a method for promoting the uptake of a platinum complex into cancer cells, which comprises administering a solution or suspension of a lipophilic platinum complex in an iodized poppyseed oil fatty acid ethyl ester, and further relates to an agent for
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to 20-fluoropregna-5,17(20)-diene-3.beta.,21-diol, 20-fluoro-pregna-5,17(20)-dien-3.beta.-ol and related compounds, to processes for their preparation, and to compositions incorporating these compounds as well as the
Background of the Invention
This invention relates to a compound having pharmacological activity, to compositions containing the compound, and to methods for the production and use of the compound. More particularly, the present invention concerns
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage application of PCT/JP2012/003995, filed Jun. 20, 2012, which claims priority from Japanese application JP 2011-147711, filed Jul. 1, 2011.
TECHNICAL FIELD
The present invention relates to photodynamic therapy using a